Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?
Part of paid clinical trials in New Orleans, Louisiana.
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Study ID
- NCT05663684
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Dacryocystitis
- Dacryostenosis
- Epiphora
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Proparacaine Hydrochloride ophthalmic solution, USP 0.5% — DRUGOne drop instilled in one eye, randomly chosen, as topical anesthetic
- Balanced salt solution — DRUGOne drop instilled in one eye, randomly chosen, as control placebo
Study Details
Purpose: It is unknown whether instillation of a drop of anesthetic ophthalmic solution into the eye such as proparacaine hydrochloride 0.5% prior to probing and irrigation of the tear duct (lacrimal drainage) system improves participant comfort during the procedure. To date, there have been no formal studies evaluating the possible benefit of this pretreatment. Methods: Participants 18 years and older who present to the Louisiana State University or associated outpatient ophthalmology clinic(s) with a complaint of epiphora (excessive tearing) who necessitate bilateral lower lid probing and irrigation of the lacrimal drainage system will be enrolled in the study. One eye will be randomized to receive a drop of the anesthetic Proparacaine hydrochloride 0.5% and the other eye will receive a control drop of Balanced Salt Solution (BSS). Probing and irrigation will then be performed in the usual fashion. The participant will then be questioned via survey on a pain scale of 1-5 as to the amount of subjective pain experienced on each side during the procedure. Expected Results: Investigators expect participants will experience statistically significantly less pain in eyes that have received a drop of Proparacaine hydrochloride 0.5% prior to performance of probing and irrigation compared to the eyes which have received the control drop.
Key Dates
- Start date
- Jun 30, 2020
- Status verified
- Dec 2022
- Primary completion
- Dec 30, 2022
- Completion
- Jan 31, 2023
Study Design
- Enrollment
- 145 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Participants with no obstruction of the lacrimal systemPatients will have received a drop of Proparacaine Hydrocholoride 0.5% ophthalmic solution in one eye and a drop of BSS in the other eye prior to probing and irrigation.
- Experimental: Participants with obstruction of the lacrimal systemParticipants who have a blockage in their tear drainage system on probing and irrigation. Participants will have received a drop of Proparacaine Hydrocholoride 0.5% ophthalmic solution in one eye and a drop of BSS in the other eye prior to probing and irrigation.
Primary Outcome Measure
Association between reduction of pain/discomfort and anesthetic use [ Time Frame: 1 minute ]
Central Contacts
- Austin M Pharo, MD(504) 568-3156
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Louisiana State University Health Sciences Center | New Orleans | Louisiana | 70112 | - |